Navigation Links
Combination of Herceptin and Hormonal therapy to Fight Cancer

Breast cancer will soon be fought with a combined treatment of hormonal therapy and the drug, Herceptin that has been shown to slow // the progress of breast cancer by over half, according to a recent report.

Following these findings a call has been made for the treatment to be made available for even more women with breast cancer.

The study showed that the addition of Herceptin to hormonal therapy kept a control over the cancer for a significantly longer period than hormonal therapy alone in patients whose advanced breast cancer was hormone receptor-positive, as well as HER2-positive.

It was found that the median progression-free survival doubled at 4.8 months for patients who received the combination therapy on comparison with the 2.4 months for patients who received hormonal therapy.

In addition it was found that another 15 per cent of high-risk patients treated with the combination therapy showed no progress of disease for at least two years. The results from the study have been presented at a meeting of the European Society for Medical Oncology.

According to experts the study demonstrated that Herceptin should be considered the essential component in the treatment of all HER2-positive breast cancers.

It has been estimated that HER2-positive breast cancer affects up to 30 per cent of women with the complaint. This is an aggressive form of the disease where special and immediate attention is required because the tumors are fast-growing and there is a higher likelihood of relapse.

So far over 3000 patients with HER2-positive breast cancer in both early and metastatic, stages have been treated with Herceptin in Australia.

The Pharmaceutical Benefits Scheme has made the drug available in it.
NLA
'"/>




Page: 1

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Drug Combinations May Boost Stroke Risk
3. Combination therapy to treat breast cancer
4. Combination regime may work against prostate cancer
5. Smoking and Breast Cancer - A Deadly Combination
6. New Drug Combination Found To Improve Memory in Alzheimer’s Patient
7. A Combination Of Drugs Effective In The Treatment Of Hormone-Refractory Prostate Cancer
8. Combination Therapy Effective In Improving Lung Cancer Survival
9. Combination Therapy Found To Improves Stroke Recovery
10. Combination Therapy Found To Be More Effective In Treating Brain Cancer
11. Combination of Clopidogrel-aspirin is better for preventing stroke than only aspirin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset ... of specialty vendors and unique items from across the nation, this holiday-themed event will ... services offered by the VNA. The boutique will be open Saturday, November 4 ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor ... on sciatica in a new episode of "Success Files," which is an award-winning ... innovation and investigates each subject in-depth with passion and integrity. , Sciatica occurs ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. ... recently contributed a medical article to the newly revamped Cosmetic Town journal ... spotlights the hair transplant procedure known as Follicular Unit Extraction (FUE). ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... and Consulting, LLC , and named its founder as ... in Tennessee , will operate under ... EnvoyHealth,s service offerings for health care partners to include ... "In an interoperable world, technology delivers ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
Breaking Medicine Technology: